NeoGenomics completes $310M Clarient acquisition

  • By Business Observer Staff
  • | 1:33 p.m. January 4, 2016
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Cancer testing firm NeoGenomics says it has completed its blockbuster deal of Clarient, a unit of GE Healthcare Life Sciences.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • April 5, 2026
Miami bank lends $27.5M for Tampa hotel sale
  • April 4, 2026
Publix opens third local store in a month
  • April 4, 2026
Waterfront restaurant owners add 30-slip deepwater marina
  • April 3, 2026
Bradenton restaurant to open second spot, in south Sarasota County

Sponsored Content